Rebecca Chambers insider trades
Open-market stock purchases and sales by Rebecca Chambers, Chief Financial Officer at Veracyte, Inc, from SEC Form 4 filings since Mar 15, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 4, 2026 | VCYT Veracyte, Inc | Sold | $106K |
| Sep 4, 2026 | VCYT Veracyte, Inc | Sold | $51.4K |
| Sep 2, 2026 | VCYT Veracyte, Inc | Sold (not open market) | $162K |
| Jun 4, 2026 | VCYT Veracyte, Inc | Sold | $78.9K |
| Jun 4, 2026 | VCYT Veracyte, Inc | Sold | $98.2K |
| Jun 2, 2026 | VCYT Veracyte, Inc | Sold (not open market) | $177K |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc | Bought (not open market) | — |
| Mar 6, 2026 | VCYT Veracyte, Inc | Bought (not open market) | — |
| Mar 6, 2026 | VCYT Veracyte, Inc | Bought (not open market) | — |
| Mar 4, 2026 | VCYT Veracyte, Inc | Sold | $156K |
| Mar 4, 2026 | VCYT Veracyte, Inc | Sold | $506K |
| Mar 2, 2026 | VCYT Veracyte, Inc | Sold (not open market) | $260K |
| Feb 26, 2026 | VCYT Veracyte, Inc | Bought (not open market) | — |
| Feb 26, 2026 | VCYT Veracyte, Inc | Sold (not open market) | $467K |
| Dec 4, 2025 | VCYT Veracyte, Inc | Sold | $398K |
| Dec 4, 2025 | VCYT Veracyte, Inc | Sold | $224K |
| Dec 2, 2025 | VCYT Veracyte, Inc | Sold (not open market) | $156K |
| Nov 5, 2025 | VCYT Veracyte, Inc | Sold | $287K |